RenovoRx, Inc. (RNXT)
1.20
+0.04
(+3.45%)
USD |
NASDAQ |
Oct 20, 16:00
1.215
+0.02
(+1.25%)
After-Hours: 20:00
RenovoRx Gross Profit (TTM) : 1.668M for June 30, 2026
Gross Profit (TTM) Chart
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.668M |
| March 31, 2026 | 1.172M |
| December 31, 2025 | 0.796M |
| September 30, 2025 | 0.586M |
| June 30, 2025 | 0.373M |
| March 31, 2025 | 0.103M |
| December 31, 2024 | 0.00 |
| September 30, 2024 | 0.00 |
| June 30, 2024 | 0.00 |
| March 31, 2024 | 0.00 |
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.00 |
| Date | Value |
|---|---|
| March 31, 2023 | -0.003M |
| December 31, 2022 | -0.006M |
| September 30, 2022 | -0.01M |
| June 30, 2022 | -0.015M |
| March 31, 2022 | -0.012M |
| December 31, 2021 | -0.009M |
| September 30, 2021 | -0.005M |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.00 |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.00 |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (TTM) Benchmarks
| Enanta Pharmaceuticals, Inc. | 60.35M |
| Travere Therapeutics, Inc. | 519.70M |
| REGENXBIO, Inc. | 135.34M |
| Krystal Biotech, Inc. | 411.03M |
| ACADIA Pharmaceuticals, Inc. | 1.038B |